Pharmaceutical

Carlyle: Reaches Definitive Agreement for Sale of Sunsho Pharmaceutical Co., Ltd. to Towa Pharmaceutical Co., Ltd.

Tokyo, Japan, December 17, 2021 – CJP SP Holding, LP, an investment fund operated and managed by global investment firm Carlyle (NASDAQ: CG), signed an agreement to sell 100% of its investment in Sunsho Pharmaceutical Co., Ltd. (“Sunsho Pharmaceutical “), a health and nutrition (” H&N “) and pharmaceutical manufacturing …

Read More »

ROSEN, ADVISOR TO LEADING INVESTORS, Encourages BioMarin Pharmaceutical Inc. Investors With Losses Over $ 100,000 To Obtain Legal Advice Before Important Dec. 22 Deadline in Securities Class Action – BMRN | national news

NEW YORK, December 14, 2021 / PRNewswire / – WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of the securities of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) between January 13, 2020 and September 3, 2021, inclusive (the “Recourse Period”), 22 December 2021 lead applicant time limit. SO …

Read More »

Zacks: Brokerages Anticipe Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) to announce – $ 0.04 BPA

Brokerages expect Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) to post earnings per share of ($ 0.04) for the current fiscal quarter, reports Zacks Investment Research. No analyst has made any estimates on Diffusion Pharmaceuticals’ earnings. Diffusion Pharmaceuticals reported earnings of ($ 0.06) per share for the same quarter last year, suggesting …

Read More »

Individual investors represent 42% of the ownership of CSPC Pharmaceutical Group Limited (HKG: 1093), while institutions represent 28%

A look at the shareholders of CSPC Pharmaceutical Group Limited (HKG: 1093) can tell us which group is more powerful. With 42% of the capital, individual investors hold the maximum number of shares in the company. That is, the group is most likely to benefit the most if the stock …

Read More »

Shanghai Fosun Pharmaceutical: An announcement has just been posted by the issuer in the Chinese section of this website, a corresponding version of which may or may not be posted in this section

Shanghai Fosun Pharmaceutical : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section [date] https://www.marketscreener.com/quote/stock/SHANGHAI-FOSUN-PHARMACEUT-6548924/news/Shanghai-Fosun-Pharmaceutical-An-announcement-has-just-been-published-by-the-issuer-in-the-Chinese-37261659/ [market] [doc type] [stock code] [stock name] An announcement has just been posted by …

Read More »

Pharmaceutical intermediates market to reach $ 37,290.33 million by 2028, according to The Insight Partners

Pharmaceutical intermediates market Pharmaceutical Intermediates Market Expected to Grow at a CAGR of 4.2% to Reach US $ 37,290.33 Million from 2020 to 2028 NEW YORK, UNITED STATES, Dec. 7, 2021 /EINPresswire.com/ – According to new research from The Insight Partners on “Pharmaceutical Intermediates Market Forecast to 2028 – COVID-19 …

Read More »

Karachi pharmaceutical companies ship free drugs worth Rs 25million to Afghanistan

Keeping their promise to support and help the neighboring country, pharmaceutical companies in Pakistan have started providing free medicine to Afghanistan. Two containers of drugs worth Rs 25 million left Karachi for Islamabad on Saturday, said Atif Iqbal, vice president of the Pakistan Pharmaceutical Manufacturing Association. Digital SAMAA. “Next week …

Read More »

Zacks: Analysts expect Teva Pharmaceutical Industries Limited (NYSE: TEVA) to post earnings per share of $ 0.74

Brokerages expect Teva Pharmaceutical Industries Limited (NYSE: TEVA) to post earnings of $ 0.74 per share for the current fiscal quarter, Zacks reports. Five analysts have released earnings estimates for Teva Pharmaceutical Industries, with estimates ranging from $ 0.67 to $ 0.81. Teva Pharmaceutical Industries reported earnings of $ 0.68 …

Read More »

Noma Al-Ahmad – The Pharmaceutical Journal

The seeds of what would become Noma Al-Ahmad’s mission were sown early in his career, with a disastrous pre-registration placement at an independent pharmacy. “It was a bunch of lies and they weren’t determined to train at all,” Al-Ahmad said. After months of doing nothing but boxes of pods, the …

Read More »

TRACON Pharmaceutical (TCON) announces regulatory approval of Envafolimab in China

Receive instant alerts for news on your actions. Claim your 1-week free trial for Street Insider Premium here. TRACON Pharmaceuticals (NASDAQ: TCON), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel, targeted cancer therapies and using a profitable, CRO-independent product development platform to partner with companies company …

Read More »